Skip to content

Lifestyle Management App for Adults With Diabetes Type

mHealth Lifestyle Management Program (LIVEN) For Adults With Diabetes Type 2: A Feasibility Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05630508
Acronym
LIVEN
Enrollment
90
Registered
2022-11-29
Start date
2022-10-01
Completion date
2026-12-31
Last updated
2025-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Type 2 diabetes management, Mhealth lifestyle management program

Brief summary

This study will evaluate whether the 12-week health coaching mobile application (LIVEN) will succeed in enhancing lifestyle behaviors in adults with Type 2 Diabetes compared to typical treatment. The mobile application's viability will be assessed in 2 parts; the first part is testing easiness and friendliness of using Liven by the patient and health coach. The second part is evaluating the suitability of Liven education material for the patients and whether the coaching program results in enhancing lifestyle behaviors and blood sugar levels. the investigators hypothesize that the 12-week online lifestyle-coaching program will be viable, and a full-scale study can proceed.

Detailed description

This study will investigate the feasibility of a 12-weeks online lifestyle (nutrition and physical behavior) coaching program through a mobile app (LIVEN) compared to standard treatment for people with type 2 diabetes. This study will be done in two phases; the first phase is the usability study (phase1), in which the user friendliness of the application will be assessed, and any technical flaws will be resolved prior and during the second phase. The second phase of the study will consist of adapting a diabetes educational material and assessing the feasibility of the program (phase2). the investigators hypothesize that the 12-week online lifestyle-coaching program will be feasible, and a full-scale study can proceed.

Interventions

OTHERSham

Receiving standard care, LIVEN educational material and access to the application

BEHAVIORALinteractive Mhealth Lifestyle behavior intervention

Receiving Standard care, LIVEN educational material and interactive LIVEN application, via having a human component which is a health coach for 3 months

Sponsors

Liven
CollaboratorUNKNOWN
Princess Nourah Bint Abdulrahman University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

The participant won't know if they got the full or sham or no intervention

Intervention model description

Participants are assigned to one of three groups in parallel for the duration of the study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults, aged 18 years or older * Arabic speakers * Capable of utilizing smartphones * Diagnosed with T2DM * Poor glycemic control: A1c \> 7.5%

Exclusion criteria

* Individuals using insulin injection * Individuals suffering from disorders that might affect intervention (e.g. amputation, enucleation of the eye, or end-stage kidney disease) * Women who are pregnant or breastfeeding * Individuals diagnosed with other types of diabetes (such as type I or MODY)

Design outcomes

Primary

MeasureTime frameDescription
recruitment rate - descriptiveimmediately after the intervention (3 months)reported as the number of participants' consented divide by the number of people that were invited to participate
retention ratesimmediately after the intervention (3 months)reported as the number of participants completing all study sessions
User friendlinessDaily application engagement data for each patient will be analyzed once at the end of the patient's 12 week program.will be assessed via user engagement tracking in the app

Secondary

MeasureTime frameDescription
Lifestyle behaviors - Health-Promoting Lifestyle profile II (Questionnaire)will be assessed one week prior to the intervention and one week after the end of the interventionwill be assessed via Health-Promoting Lifestyle profile II. HPLP-II is a 4-point Likert scale with 52 items including six subscales: health responsibility, physical activity, nutrition, spiritual growth, interpersonal relationships, and stress management. scores range from 52 to 208. higher scores indicate better outcome.
physical performance assessments - upper body muscle strength in kgwill be assessed one week prior to the intervention and one week after the end of the interventionwill be assessed via Hand Grip Strength using dynameter (power in kg), higher scores indicate higher physical performance
Glycemic control - A1cwill be assessed one week prior to the intervention and one week after the end of the interventionwill be assess via A1c blood test will be reported as percentage. higher % indicate worse outcome
physical performance assessments - endurancewill be assessed one week prior to the intervention and one week after the end of the interventionwill be assessed via 6-minute walk test (distance in m). higher distance indicates higher endurance
physical performance assessments - lower body muscle strength in countswill be assessed one week prior to the intervention and one week after the end of the interventionwill be assessed via Sit to Stand Test (count), higher counts indicate higher physical performance
Glycemic control - continuous glucose mentoring (CGM)will be assessed one week prior to the intervention and one week after the end of the interventionwill be assess via continuous glucose mentoring (CGM) as variability. higher variability indicates worse outcome
Body composition - fat free mass (%) physiological parameterwill be assessed one week prior to the intervention and one week after the end of the interventionwill be assessed via Bioelectrical Impedance Analysis (BIA). fat free mass (%) will reported as percentage. higher % indicate better outcome

Countries

Saudi Arabia

Contacts

Primary ContactShaima A Alothman, PhD
shaalothman@pnu.edu.sa+966503952053

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026